Travaux scientifiques

Doç. Dr. Şefika Nur Aksoy

23 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Aksoy ŞN, Savaş E, Sucu M, Kisacik B, Kul S, Zengin O. Association between red blood cell distribution width and disease activity in patients with Behçet's disease. J Int Med Res. 2015 Dec;43(6):765-73

    Source : page de profil sur livhospital.com

  2. Akcali A, Zengin F, Aksoy SN, Zengin O. Fatigue in Multiple Sclerosis: Is it related to cytokines and hypothalamic-pituitary-adrenal axis? Mult Scler Relat Disord. 2017 Jul;15:37-41.

    Source : page de profil sur livhospital.com

  3. Tabur S, Aksoy ŞN, Korkmaz H, Ozkaya M, Aksoy N, Akarsu E. Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma. Tumour Biol. 2015 Apr;36(4):2667-74.

    Source : page de profil sur livhospital.com

  4. Dai AI, Aksoy SN, Demiryürek AT. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity. J Child Neurol. 2016 Feb;31(2):184-9

    Source : page de profil sur livhospital.com

  5. Tabur S, Korkmaz H, Ozkaya M, Aksoy SN, Akarsu E. Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy? Diabetol Metab Syndr. 2015 Apr 24;7:36

    Source : page de profil sur livhospital.com

  6. Dai AI, Demiryürek S, Aksoy SN, Perk P, Saygili O, Güngör K. Maternal Iron Deficiency Anemia as a Risk Factor for the Development of Retinopathy of Prematurity. Pediatr Neurol. 2015 Aug;53(2):146-50.

    Source : page de profil sur livhospital.com

  7. Korkmaz H, Tabur S, Savaş E, Özkaya M, Aksoy ŞN, Aksoy N, Akarsu E. Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases. Balkan Med J. 2016 Sep;33(5):547-551.

    Source : page de profil sur livhospital.com

  8. Çetkin M , Demirel C, Kızılkan N, Aksoy N, Erbağcı H. Evaluation of the mobile phone electromagnetic radiation on serum iron parameters in rats. Afr Health Sci. 2017 Mar; 17(1): 186–190.

    Source : page de profil sur livhospital.com

  9. Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis. Savas E, Aksoy N, Pehlivan Y, Sayiner ZA, Oztürk ZA, Tabur S, Orkmez M, Onat AM. Wien Klin Wochenschr. 2014 Jun;126(11-12):341-6.

    Source : page de profil sur livhospital.com

  10. Aksoy SN , Saygılı EI , Bulbul F , Bahar A , Savas H, Vırıt O , Altındag A , Bayram A and Tarakçıoğlu M. Myeloperoxidase enzyme levels and oxidative stress in bipolar disorders. Afr. J. Biotechnol 9 (22), 3318-3323, May 2010

    Source : page de profil sur livhospital.com

  11. Saygili E.I, Aksoy SN, Gurler B, A. Aksoy, O. Erel & M. Ozaslan Oxidant/Antioxidant Status of Patients with Diabetic and Senile Cataract. Biotechnol. & Biotechnol. Eq., 24(1), 1648-1652, 2010

    Source : page de profil sur livhospital.com

  12. Aksoy SN, Erbagci Z, Saygili EI, Sever T, Erbagci AB, Pehlivan S. Analysis of myeloperoxidase promotor polymorphism and enzyme activity in Turkish patients with vitiligo. Eur J Dermatol. Nov-Dec 2009;19(6):576-80

    Source : page de profil sur livhospital.com

  13. Aksoy N, Aksoy M, Cakmak M, Gergerlioglu HS, Davutoglu V, Soydinc S, Meram I “ Increased homocysteine in heart failure: a result of renal impairment? “,Clin chem Lab Med .44(11):1324-1329 (2006)

    Source : page de profil sur livhospital.com

  14. Aksoy N, Aksoy M, Bagci C, Gergerlioğlu HS, Çelik H, Herken E, Yaman A, Tarakçıoğlu M,Soydinç S, Sari I, Davutoğlu. ‘’Pistachio intake increases high density lipoprotein levels and inhibits low density lipoprotein oxidation in rats’’,Tohoku J Exp Med.212(1):43-8 (2007)

    Source : page de profil sur livhospital.com

  15. Aksoy N, Ozer O, Sari I, Sucu M, Aksoy M, Geyikli I. ‘’Contribution of Renal Function Impairment to Unexplained Troponin T Elevations in Congestive Heart Failure. Renal Failure, 31(4):272–277 (2009)

    Source : page de profil sur livhospital.com

  16. Saygili EI, Aksoy N, Pehlivan M, Sever T, Yilmaz M, Cimenci IG, Pehlivan S. Enzyme levels and G-463A polymorphism of myeloperoxidase in chronic lymphocytic leukemia and multiple myeloma. Leuk Lymphoma. 2009 Oct 9.

    Source : page de profil sur livhospital.com

  17. Dinçkal MH, Aksoy SN, Aksoy M,Davutoğlu,Dinçkal N, Akdemir I,”QT dispersion in the risk stratification of patients with unstable angina : correlation with clinical course ,troponin T and scintigraphy.” Acta Cardiol.59(3):283-9 (2004)

    Source : page de profil sur livhospital.com

  18. Dinçkal MH, Aksoy N, Aksoy M, Davutoğlu V,Soydinç S,Kirilmaz A,Dinçkal N,Akdemir I “Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia.”Acta Cardiol.58(5):389-96(2003)

    Source : page de profil sur livhospital.com

  19. Akdemir I, Aksoy N, Aksoy M, Davutoğlu V, Dinçkal H,” Does exercise induced severe ischemia result in elevation of plasma troponin-T level in patients with chronic coronary disease,”Acta Cardiol.,57(1):13-8 (2002)

    Source : page de profil sur livhospital.com

  20. Dinçkal MH, Aksoy N, Aksoy M, Davutoğlu, Dinçkal N, Soydinç S, Akdemir I,”Acute rest perfusion imaging in high risk unstable angina :association with troponin T and clinical endpoints”,Int J Cardiovasc Imaging,19(6):511-7 (2003)

    Source : page de profil sur livhospital.com

  21. Sari I, Baltaci Y, Bagci C, Davutoglu V, Erel O, Celik H, Ozer O, Aksoy N, Aksoy M. Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: A prospective study. Nutrition. 2009; 1–6

    Source : page de profil sur livhospital.com

  22. Ozer O, Davutoglu V, Ercan S, Akcay M, Sari I, Sucu M, Celik A, Aksoy N, Cicek H, Al B.Plasma urotensin II as a marker for severity of rheumatic valve disease.Tohoku J Exp Med. 2009 May;218(1):57-62

    Source : page de profil sur livhospital.com

  23. Erbağcı AB, Deveci R, Akarsu E, Tiryaki Ö, Aksoy ŞN. Effect of intensive insulin therapy on systemic nitric oxide levels and adenosine deaminase activity in secondary sulfonylurea failure. Biochemia Medica 2009;19(2):166–76

    Source : page de profil sur livhospital.com